Clinical trial
Assessment of Arformoterol for COPD Using Hyperpolarized 3He MRI
NCT00846287 is registered in ClinicalTrials.gov with University of Massachusetts, Worcester as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessment of Arformoterol for COPD Using Hyperpolarized 3He MRI
- Lead sponsor
- University of Massachusetts, Worcester
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 30, 2008
- Completion date
- April 30, 2011
- Enrollment
- 16 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic obstructive pulmonary disease